Alginate encapsulation
Alginate encapsulation has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Oct 26, 2026: “Combined B2M Knockout and Alginate Encapsulation Reduces Immune Rejection of iPSC-Derived Pancreatic Progenitors”.
1 paper studies it1 findingUpdated
1 new paper in 30 daysSee all 1 papers on alginate encapsulation
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
- 1 lab in 1 country
- Funder: Russian Science Foundation
- Animals1
What did studies of alginate encapsulation find?
1Studies of alginate encapsulation measured one outcome, T-cell activation.
T-cell activation
downin human cells1
1 study
T-cell activation
downin human cells1
Alginate encapsulation decreases T-cell activation in human cells (Co-culture with encapsulated progenitors versus non-encapsulated controls).
“T-cells did show residual activation after 7 days of co-culture with encapsulated progenitors, albeit significantly reduced in comparison with non-encapsulated controls.”
CellsCo-culture with encapsulated progenitors versus non-encapsulated controlsT cell7 days
Cells